Award
Delivery Order #SPE2DP26F2980
Delivery Order for Lidocaine Hydrochloride under Pharmaceutical Supply Contract
Buyer
Defense Logistics Agency
Award Amount
$6.83
Ceiling
$6.83
Awarded
February 22, 2026
Period of Performance
Feb 22, 2026 – Feb 23, 2026
Identifier
SPE2DP26F2980
NAICS
424210
This award represents a delivery order under a definitive indefinite delivery vehicle (IDV) contract with DMS Pharmaceutical Group Inc., a distributor specializing in essential pharmaceutical products. The order specifically procures lidocaine hydrochloride, a critical local anesthetic used widely in medical treatments. This procurement is significant for ensuring the agency’s continuous supply of vital medications that support patient care and health services. The scope covers the delivery of this pharmaceutical product to a specified location for immediate use. This delivery order falls under a larger, multi-year pharmaceutical supply contract that secures a broad portfolio of drugs, reflecting an ongoing strategic procurement effort rather than a sole-source award. The order’s performance is set within a short timeframe, highlighting a timely fulfillment requirement within the broader long-term contract context.
Description
8511936316!LIDOCAINE HYDROCHLO